Omnicell Inc（OMCL）股票分析OMCLOmnicell Inc

Omnicell, Inc. is a healthcare technology provider focused on autonomous medication management, by unifying automation and AI-enabled intelligence, optimized by expert services, to drive clinical and business outcomes that are helping to improve efficiency and enhance patient safety for healthcare facilities. The Company is focused on helping its customers define and deliver a medication management strategy designed for pharmacists and nurses to focus on patient care rather than administrative tasks, and to drive improved clinical, operational, and financial outcomes across all care settings. It provides a range of points of care medication and supplies dispensing systems, including automated systems and offers advanced automation solutions, including robotics designed to automate work, streamline workflows, and reduce human error. It provides central pharmacy automation solutions for both medication dispensing and IV compounding and provides patient engagement solutions. It operates in the Healthcare sector (ELECTRONIC COMPUTERS industry).

Omnicell Inc appears to be a good buy right now, with a current price of $37.75 and a strong RSI of 75.347 indicating bullish momentum. The company has shown significant revenue growth, with Q2 2026 revenue reported at $312.2 million, and a gross margin of 48.98%, which is a positive indicator of profitability. However, the main risk is the insider selling activity, which has increased by 151.38% over the last month, suggesting potential concerns among insiders about the stock's near-term performance.

8 analysts cover OMCL: 5 rate it Buy, 3 Hold and 0 Sell. The average price target is 54.20.